MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β

BACKGROUND: In prostate cancer (PCa), the common treatment involving androgen ablation alleviates the disease temporarily, but results in the recurrence of highly aggressive and androgen-independent metastatic cancer. Therefore, more effective therapeutic approaches are needed. It is known that aber...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Paul, Deng, Zhiyong, Wan, Meimei, Huang, Weiwei, Cramer, Scott D, Xu, Jianfeng, Lei, Ming, Sui, Guangchao
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881117/
https://www.ncbi.nlm.nih.gov/pubmed/20478051
http://dx.doi.org/10.1186/1476-4598-9-108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881117/
https://www.ncbi.nlm.nih.gov/pubmed/20478051
http://dx.doi.org/10.1186/1476-4598-9-108

Ejemplares similares